Molecular Partners MOLN Surges 492 as Biotech Stock Nears Key Resistance at 441 US Labor Market Shows Continued Strength Jobs Data Exceeds Expectations for Second Consecutive Month ASBA Q1 2026 Earnings EPS Beats Estimates by 188 Security Price Edges Lower Plus500 Reports 11 Quarterly Revenue Growth Reaffirms FullYear Expectations